Jane Street Group, LLC Red Hill Biopharma Ltd. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.14 - $695.9 $2,010 - $10 Million	14,364 New	14,364 $2,000
Q2 2022 Aug 16, 2022	SELL	$0.63 - $2.58 $11,028 - $45,162	-17,505 Reduced 61.91%	10,770 $9,000
Q1 2022 May 17, 2022	BUY	$1.65 - $3.12 $3,298 - $6,236	1,999 Added 7.61%	28,275 $72,000
Q4 2021 Feb 15, 2022	SELL	$2.31 - $5.85 $2,363 - $5,984	-1,023 Reduced 3.75%	26,276 $64,000
Q3 2021 Nov 16, 2021	BUY	$4.55 - $10.36 $29,911 - $68,106	6,574 Added 31.72%	27,299 $123,000
Q2 2021 Aug 16, 2021	BUY	$5.98 - $7.51 $123,935 - $155,644	20,725 New	20,725 $142,000
Q2 2020 Aug 17, 2020	SELL	$4.6 - $8.6 $96,765 - $180,909	-21,036 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.51 - $6.17 $73,836 - $129,792	21,036 New	21,036 $95,000
Q3 2019 Nov 14, 2019	SELL	$6.46 - $8.37 $383,756 - $497,219	-59,405 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$6.34 - $8.8 $376,627 - $522,764	59,405 New	59,405 $384,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $557M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.